SCHEMBL9946065

SCHEMBL9946065

CB(O)c1cc(C)cc(Br)c1OCc1ccccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.44
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
ALDH1A1 P00352 5/20 0.44
GAA P10253 5/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
BLM P54132 2/20 0.44
ALOX12 P18054 1/20 0.44
PLEC Q15149 1/20 0.44
THRB P10828 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 7/20 0.43
ALPG P10696 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 3/20 0.41
THRA P10827 1/20 0.39
MAOB P27338 2/20 0.39
TDP1 Q9NUW8 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16687437 0.92 MAPT (0.46) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL12440961 0.81 MAPT (0.50) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL9946068 0.80 THRB (0.42) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL12514203 0.79 MAPT (0.49) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL13430008 0.79 MAPT (0.46) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL9946067 0.79 MAOB (0.45) MAPTTHRBLMNATHRAMAOB
SCHEMBL9946066 0.78 THRA (0.51) MAPTMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL9893400 0.77 CYP1A2 (0.46) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL13429704 0.77 MEN1 (0.47) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL9946069 0.76 THRA (0.49) THRBTHRAMAOBPARP15PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149693-A1 THERAPEUTIC COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149693-A1 THERAPEUTIC COMPOUNDS HTR2C, GRK2, GRK3 MAPT 2718/4885MEN1 4590/4885KMT2A 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.